Electronic medical record-based model to predict the risk of 90-day readmission for patients with heart failure

Table 3 Medications during hospitalization

Characteristic	Readmission (n = 86)	Non-readmission (n = 160)	p-value
ACEs/ARBs [n (%)]	61 (73.6)	135 (85.8)	0.024^*
Beta blockers [n (%)]	61 (71.9)	124 (78.7)	0.27
Ca channel blockers [n (%)]	43 (45.4)	60 (40.4)	0.47
Thiazide [n (%)]	12 (10.7)	11 (7.8)	0.75
Aldosterone blockers [n (%)]	57 (68.6)	95 (72.4)	0.60
Loop diuretics [n (%)]	41 (60.3)	61 (64.6)	0.48
Nitrates [n (%)]	66 (79.3)	107 (65.2)	0.023^*

ACEs/ARBs angiotensin converting enzyme inhibitors or angiotensin II receptor blockers
^*Denotes p < 0.05, Differences between readmission group and non-readmission group were tested for statistical significance using Pearson’s Chi-square test

ISSN: 1472-6947